[基于β细胞功能的儿科非酒精性脂肪肝疾病的临床分类]
1Department of Endocrinology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.
Zhonghua er ke za zhi = Chinese journal of pediatrics
|January 15, 2026
概括
儿科非酒精性脂肪性肝病 (NAFLD) 的新分类使用来自健康儿童的胰岛素抵抗水平. 该系统将患有NAFLD的肥胖儿童分为三个亚型,有助于临床评估和管理.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是肥胖儿童日益关注的问题.
- 胰岛素抵抗是NAFLD发展和进展的关键因素.
- 目前对儿科NAFLD的分类方法可能无法完全捕捉代谢复杂性.
研究的目的:
- 建立基于胰岛素耐药性的儿科NAFLD的临床分类.
- 以健康儿童的胰岛素耐药性 (HOMA-IR) 均质模型评估为参考.
- 评估这种新分类在患有NAFLD的肥胖儿童中的临床实用性.
主要方法:
- 对患有NAFLD的健康和肥胖儿童进行了回顾性队列研究.
- 在健康儿童中计算特定阶段的第95百分位数 (P95) HOMA-IR.
- 对NAFLD患者的"相对HOMA-IR倍数"的导出.
- 根据ROC分析的切线,分类为非胰岛素抵抗性,轻度胰岛素抵抗性和严重胰岛素抵抗性亚型.
- 分析NAFLD亚型与代谢异常之间的关联.
主要成果:
- 为了分类,确定了1.78的相对HOMA-IR多重切线.
- 在研究中,NAFLD患者被分为:非胰岛素耐药 (25.3%),轻度胰岛素耐药 (32.9%) 和严重胰岛素耐药 (41.8%).
- 在性别,BMI,血压,糖化血红蛋白和胰岛素功能方面观察到群体之间的显著差异.
- 严重的胰岛素耐药性与过高甘油三血,高尿血,高血压和非酒精性脂肪肝炎有关.
- 严重的胰岛素抵抗也与较低的HDL胆固醇有关,与轻度的胰岛素抵抗相比.
结论:
- 建议基于健康儿童的HOMA-IR进行儿科NAFLD的新型分类系统.
- 这种分类有效地将患有NAFLD的肥胖儿童分为基于胰岛素抵抗的三个不同的亚型.
- 确定的亚型与各种代谢异常有显著的关联,为评估和管理提供临床实用性.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Pharmacokinetics in Pediatric Patients: Drug Metabolism
195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K


